Cancer Research Technology Limited
260Patents
210Active
260Granted
55Portfolio score
Filing activity: Jul 18, 1997 → Jan 25, 2023 · 45 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6667337B2 | Combination therapy for cancer | Human Necessities | 119 | Expired |
| US7585893B2 | Anti-cancer composition comprising DMXAA or related compound | Human Necessities | 109 | Expired |
| US7510830B2 | Cancer treatment by combination therapy | Human Necessities | 109 | Expired |
| US7462642B2 | Anti-cancer combinations | Human Necessities | 109 | Expired |
| US6916949B2 | Methods of chemical systhesis of phenolic nitrogen mustard prodrugs | Chemistry; Metallurgy | 59 | Expired |
| US7235585B2 | Enzyme activated self-immolative n-substituted nitrogen mustard prodrugs | Chemistry; Metallurgy | 57 | Expired |
| US7951819B2 | Imidazo[4, 5-B]pyridin-2-one and oxazolo[4, 5-B] pyridin-2-one compounds and analogs thereof as cancer therapeutic compounds | Human Necessities | 34 | Active |
| US7612201B2 | Pyrazole compounds | Chemistry; Metallurgy | 28 | Expired |
| US7351701B2 | Therapeutic compounds | Chemistry; Metallurgy | 27 | Expired |
| US7632855B2 | Pyrazole compounds as HSP90 inhibitors for the treatment of cancer | Chemistry; Metallurgy | 26 | Expired |
| US7696204B2 | Pharmaceutical compounds | Chemistry; Metallurgy | 24 | Active |
| US7056690B2 | Detection of dysplastic or neoplastic cells using anti-MCM2 antibodies | Physics | 23 | Expired |
| US8431596B2 | [1,2,4]triazolo[1,5-a]pyridine and [1,2,4]triazolo[1,5-c]pyrimidine compounds and their use | Chemistry; Metallurgy | 22 | Active |
| US8440798B2 | Generation of a cancer-specific immune response toward MUC1 and cancer specific MUC1 antibodies | Emerging Cross-Sectional Technologies | 19 | Active |
| US8058045B2 | Pyrazin-2-yl-pyridin-2-yl-amine and pyrazin-2-yl-pyrimidin-4-yl-amine compounds and their use | Chemistry; Metallurgy | 19 | Active |
| US7625922B2 | Imidazo[4,5-b]pyridin-2-one and oxazolo[4,5-b]pyridin-2-one compounds and analogs thereof as therapeutic compounds | Human Necessities | 17 | Expired |
| US7247734B2 | 3,4-diarylpyrazoles and their use in the therapy of cancer | Chemistry; Metallurgy | 14 | Expired |
| US8367658B2 | Pyrazin-2-yl-pyridin-2-yl-amine and pyrazin-2-yl-pyrimidin-4-yl-amine compounds and their use | Chemistry; Metallurgy | 13 | Active |
| US7868040B2 | Anti-cancer combinations | Human Necessities | 13 | Active |
| US7498034B2 | Imaging, diagnosis and treatment of disease | Chemistry; Metallurgy | 13 | Expired |
| US6858633B1 | Substituted 2-arylbenzazole compounds and their use as antitumour agents | Chemistry; Metallurgy | 13 | Expired |
| US7241618B2 | Expression system | Chemistry; Metallurgy | 13 | Expired |
| US8383816B2 | Aryl-quinolyl compounds and their use | Human Necessities | 12 | Active |
| US9604994B2 | Thienopyrimidine inhibitors of atypical protein kinase C | Chemistry; Metallurgy | 11 | Active |
| US7268126B2 | Polymorphic and amorphous forms of the phosphate salt of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-ce]indol-6-one | Chemistry; Metallurgy | 11 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.